Logo-ps
Pharm Sci. 2023;29(1): 1-19. doi: 10.34172/PS.2022.23

Review Article

Modulation of Nrf2 by Activation of Estrogen Receptor β as a Therapeutic Strategy to Prevent Cancer Development and Overcome Inflammation-Related Drug Resistance in Breast Cancer

Emdormi Rymbai 1 ORCID, Deepa Sugumar 1, Jubie Selvaraj 2, Ram Kothandam 3, Divakar Selvaraj 1 * ORCID

Cited by CrossRef: 0


1- Kopacz A, Tomaszewska Z, Piechota-Polanczyk A. Estrogen receptors and the NRF2 pathway: bridging hormonal regulation and stress response in the gut. Front Endocrinol. 2026;17 [Crossref]

   Indexing & Abstracting: